Operose Advisors’s Exelixis EXEL Stock Holding History

Operose Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-36	Closed	-$1.54K	–	573
2026 Q1	$1.54K	Buy	+36	New	+$1.55K	﹤0.01%	511

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Operose Advisors's EXEL Position: Q2 2026 in Review

Operose Advisors sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 36 shares — an estimated $1.54K sold.

Operose Advisors first reported a position in EXEL in Q1 2026 and held it in 1 quarter. The position peaked at $1.54K in Q1 2026. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

Operose Advisors reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
Operose Advisors sold 36 Exelixis shares in Q2 2026, an estimated $1.54K.
Operose Advisors first reported a position in Exelixis in Q1 2026 and held it in 1 quarter.
Operose Advisors's Exelixis position peaked at $1.54K in Q1 2026.
756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.